Tesamorelin + Ipamorelin Blend
Dual GHRH + GHS Receptor Stack
Combined research blend pairing Tesamorelin, a stabilized GHRH analog, with Ipamorelin, a selective ghrelin/GHS-R1a agonist, in a single lyophilized vial. The two-pathway design is widely used in preclinical studies of synergistic GH-axis activation. Subject of ongoing investigation into pulsatile somatotropic release. For laboratory research use only.
Co-activates the GHRH receptor and the ghrelin/GHS-R1a receptor on somatotrophs, amplifying GH release through complementary cAMP and phospholipase-C pathways.
For Research Use Only. Sold for in vitro laboratory research. Not for human or veterinary consumption. By purchasing, you confirm you are 21+ and a qualified research professional.
Combined GHRH analog + selective GHS-R1a agonist.
Every batch of Tesamorelin + Ipamorelin Blend ships with an independently conducted Certificate of Analysis by Janoshik Analytical or Bioviridian. The COA includes HPLC-MS chromatogram, mass spec confirmation, endotoxin levels, and heavy metals screening.
Batch number is printed on the vial label and included in your order confirmation email. Look it up at pepidyn.com/coa.
